Janus Henderson Group PLC lifted its holdings in Phibro Animal Health Corp (NASDAQ:PAHC) by 1,961.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 230,340 shares of the company’s stock after buying an additional 219,165 shares during the period. Janus Henderson Group PLC’s holdings in Phibro Animal Health were worth $7,601,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of PAHC. Truvestments Capital LLC bought a new position in Phibro Animal Health during the 1st quarter valued at about $36,000. Quantamental Technologies LLC bought a new position in Phibro Animal Health during the 4th quarter valued at about $60,000. Advisory Services Network LLC grew its holdings in Phibro Animal Health by 20.4% during the 4th quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock valued at $71,000 after purchasing an additional 372 shares during the last quarter. Advisors Asset Management Inc. grew its holdings in Phibro Animal Health by 52.3% during the 4th quarter. Advisors Asset Management Inc. now owns 2,536 shares of the company’s stock valued at $82,000 after purchasing an additional 871 shares during the last quarter. Finally, BNP Paribas Arbitrage SA grew its holdings in Phibro Animal Health by 926.8% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,713 shares of the company’s stock valued at $156,000 after purchasing an additional 4,254 shares during the last quarter. Hedge funds and other institutional investors own 50.88% of the company’s stock.
Shares of PAHC stock opened at $28.88 on Friday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41. The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of 16.60, a P/E/G ratio of 4.23 and a beta of 0.63. Phibro Animal Health Corp has a one year low of $28.26 and a one year high of $54.62.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.66%. Phibro Animal Health’s dividend payout ratio is currently 27.59%.
Several equities analysts recently commented on the stock. BidaskClub upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Tuesday, May 7th. Gabelli upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 price target on the stock in a report on Wednesday, May 8th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Monday, April 29th. Finally, ValuEngine upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Three research analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $43.50.
ILLEGAL ACTIVITY NOTICE: “Janus Henderson Group PLC Boosts Stake in Phibro Animal Health Corp (PAHC)” was published by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/05/18/janus-henderson-group-plc-boosts-stake-in-phibro-animal-health-corp-pahc.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.